Yi Feng Shi
Plus aucun poste en cours
Profil
Mr. Yi Feng Shi is Vice President-Operations & Head-Waigaoqiao Site at Wuxi PharmaTech (Cayman) Inc.
Mr. Shi was previously employed as Vice President-Operations & Compliance Officer by WuXi AppTec Co., Ltd.
and Research Scientist by GL Synthesis, Inc.
He received his undergraduate degree from the University of Shanghai Science & Technology.
Anciens postes connus de Yi Feng Shi
| Sociétés | Poste | Fin |
|---|---|---|
| WUXI APPTEC CO., LTD. | Compliance Officer | 01/12/2012 |
GL Synthesis, Inc.
 GL Synthesis, Inc. Chemicals: SpecialtyProcess Industries GL Synthesis, Inc. is an American company that manufactures and wholesales chemicals. | Corporate Officer/Principal | 01/01/2002 |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Corporate Officer/Principal | - |
Formation de Yi Feng Shi
| University of Shanghai for Science & Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| WUXI APPTEC CO., LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
GL Synthesis, Inc.
GL Synthesis, Inc. Chemicals: SpecialtyProcess Industries GL Synthesis, Inc. is an American company that manufactures and wholesales chemicals. | Process Industries |
Wuxi PharmaTech (Cayman), Inc.
 Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |